𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benign monoclonal gammopathy and peripheral neuropathy

✍ Scribed by E. Ö Sby ; L. Noring; R. Hast; K. G. Kjellin; E. Knutsson; Å Sidén

Book ID
114709635
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
550 KB
Volume
51
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term clinical and neurophysiologica
Long-term clinical and neurophysiological follow-up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy
✍ Sawanthana Ponsford; Hugh Willison; Jean Veitch; Richard Morris; P.K. Thomas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 2 views

The incidence of hematological malignancy in patients with monoclonal gammopathy of undetermined significance (MGUS) has been assessed as 17% to 25%. To ascertain whether this is true of neuropathy associated with MGUS, a long-term (5-42 years) retrospective clinical and neurophysiological follow-up

Peripheral neuropathy in patients with b
Peripheral neuropathy in patients with benign monoclonal gammopathy — A pilot study
✍ L. Noring; E. Ösby; R. Hast; K. G. Kjellin; E. Knutsson; Å. Sidén 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 706 KB

It is well known that peripheral neuropathy occurs in patients with myeloma or macroglobulinaemia, but its pathogenesis is still obscure. In recent years, neuropathy has also been reported in association with benign monoclonal or oligoclonal gammopathy. Modern histo-immunological methods have reveal

Monoclonal gammopathy and neuropathy
Monoclonal gammopathy and neuropathy
✍ Alan Pestronk 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

below 100 pgiml may be abnormal, we recommend the use of more sensitive radio-and immunoenzymatic tests, able to detect less than 4 pgiml of TNF-a [e.g., 91. Supplementation of freshly obtained samples with protease inhibitors may also be useful in evaluating levels of circulating human cytokines.